Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses-Reference-Cited by-同舟云学术

Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses

Published:2014-05 Issue:5 Volume:1841 Page:811-825
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Ferraz Maria J.,Kallemeijn Wouter W.,Mirzaian Mina,Herrera Moro Daniela,Marques Andre,Wisse Patrick,Boot Rolf G.,Willems Lianne I.,Overkleeft H.S.,Aerts J.M.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference211 articles.

1. Glycosphingolipids—nature, function, and pharmacological modulation;Wennekes;Angew. Chem. Int. Ed. Engl.,2009

2. Lysosomal disorders: from storage to cellular damage;Ballabio;Biochim. Biophys. Acta,2009

3. Lysosomal storage diseases;Gieselmann;Biochim. Biophys. Acta,1995

4. The cellular pathology of lysosomal diseases;Cox;J. Pathol.,2012

5. Gaucher disease;Beutler,2001

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method;Clinica Chimica Acta;2024-07

2. AAV delivery ofGBA1suppresses α-synuclein accumulation in Parkinson’s disease models and restores motor dysfunction in a Gaucher’s disease model;2024-06-26

3. Endocrinological and metabolic profile of Gaucher disease patients treated with enzyme replacement therapy;Journal of Pediatric Endocrinology and Metabolism;2024-04-17

4. Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease;Cell Structure and Function;2024

5. Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study;Diagnostics;2023-08-30